Burjeel Holdings, a healthcare provider in the MENA region, has announced plans to launch in vitro fertilisation (IVF) services, expanding its comprehensive women’s health portfolio.
This move is part of the group’s strategy to broaden its women’s and children’s healthcare offerings.
Through the addition of IVF offerings, the group aims to provide an integrated approach to women’s health, ensuring continuous care through all life stages.
The Trust Fertility Clinic at Burjeel Medical City (BMC), the group’s flagship facility, will be at the forefront of this expansion.
This clinic will offer a wide array of fertility treatments such as egg retrieval, AI-driven embryo selection, embryo transfer, fertility evaluations, intrauterine insemination (IUI), and IVF consultations.
Furthermore, reproductive medicine consultations and laparoscopic surgery to diagnose and treat fertility-associated conditions will be offered at the facility.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe clinic’s integration into BMC will complement the existing advanced gynaecology, foetal medicine, and paediatric sub-specialties to offer women a seamless healthcare journey from conception to delivery.
The Trust Fertility Clinic is said to be the largest fertility facility in the UAE, offering fertility treatments.
Burjeel Holdings, established in 2007, offers super-speciality healthcare services in the UAE and Oman and is expanding its presence in Saudi Arabia.
The group’s healthcare ecosystem spans primary to quaternary medical care, with a network comprising 89 assets, including 19 hospitals and 47 medical centres.
Burjeel Holdings CEO John Sunil said: “The UAE in-vitro fertilisation market is experiencing rapid growth and transformation, reflecting social trends and advances in reproductive technologies.
“The addition of fertility services not only strengthens our comprehensive women’s healthcare portfolio but also positions us to meet the growing demand in the region.
“This expansion reflects our commitment to leading the region in holistic women’s health services, empowering patients with the best possible care on their journey to parenthood.”
The latest development comes after Burjeel Holdings opened the ‘Nader Orthopedics & Sports Medicine Center’ in Abu Dhabi.